A share price of Immunome Inc [IMNM] is currently trading at $24.32, up 0.75%. An important factor to consider is whether the stock is rising or falling in short-term value. The IMNM shares have gain 8.19% over the last week, with a monthly amount glided 4.60%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Immunome Inc [NASDAQ: IMNM] stock has seen the most recent analyst activity on January 29, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $30. Previously, Wedbush started tracking the stock with Outperform rating on December 19, 2023, and set its price target to $12. On October 29, 2021, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $35 on the stock.
Immunome Inc experienced fluctuations in its stock price throughout the past year between $4.44 and $30.96. Immunome Inc [NASDAQ: IMNM] shares were valued at $24.32 at the most recent close of the market.
Analyzing the IMNM fundamentals
Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at -2.22%, Pretax Profit Margin comes in at -2.15%, and Net Profit Margin reading is -2.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.24, Equity is -1.95 and Total Capital is -0.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 23.43 points at the first support level, and at 22.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.81, and for the 2nd resistance point, it is at 27.31.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Immunome Inc [NASDAQ:IMNM] is 3.96. On the other hand, the Quick Ratio is 3.96, and the Cash Ratio is 3.92. Considering the valuation of this stock, the price to sales ratio is 132.87, the price to book ratio is 48.84.
Transactions by insiders
Recent insider trading involved SIEGALL CLAY B, President and CEO, that happened on Oct 02 ’23 when 0.17 million shares were purchased. Chief Strategy Officer, Turner Bruce completed a deal on Oct 02 ’23 to buy 42300.0 shares.
